Beijing Tiantan Biological Products Corporation Limited Class ASSE: 600161

Announcement on the Receipt of Clinical Trial Summary Report by a Subsidiary

· Issued by Beijing Tiantan Biological Products Corporation Limited Class A via Shanghai Stock Exchange
Announcement on the Receipt of Clinical Trial Summary Report by a Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment